63

DAFTAR PUSTAKA

Amant , Mirza, Creutzberg, 2012. 'Figo Cancer Report 2012 Cancer of the corpus
uteri'. International Journal of Gynecology & Obstetrics, vol. 119, pp.110
117.

Appel, Edelweiss, Rivero, Fleck, Rivero, Rivoire, Mnego, et al., 2008. 'P53 and
BCL-2 as Prognostic Markers in Endometrial Carcinoma'. Pathol. Oncol.
Res, vol.14, pp.2330.

Badan Registrasi Kanker IAPI, 2013. Kanker di Indonesia Tahun 2009 Data
Histopatologik. Direktorat Jendral Pelayanan Medik Departemen Kesehatan
R.I, Jakarta.

Benedetti P.P, Basile S, Maneschi F, Alberto L.A, Signorelli M, Scambia G,

Angioli R, Tateo S, et al., 2008. 'Systematic Pelvic Lymphadenectomy vs
No Lymphadenectomy in Early-Stage Endometrial Carcinoma'. J Natl
Cancer Inst, vol.100, pp.17071716.

Bernardini M.Q, May T, Khalifa M.A, Bland A.E, Nofech-Mozes S, Berchuck A,

Covens A, Havrilesky L, 2009. 'Evaluation of Two Management Strategies
for Preoperative Grade 1 Endometrial Cancer'. Obstet Gynecol, vol.114,
pp.715.

Boren T. and Miller D, 2010. 'An Update on Endometrial Cancer'. Texas Medical
Assosiation, vol.106, pp.50-55.

Cahyanti R.D, 2008. Bcl-2 and Apoptotic Index in Simple and Complex Non-
Atypical Endometrial Hyperplasia. Thesis. University of Diponegoro.

Cancer Research UK, 2013. 'Uterine (Womb) Cancer Incidence Statistics. London.

Cecka F, Hornychova H, Melichar B, Ryska A, Jandik P, Mergancova J, Klozova

H-Urminska, 2008. 'Expression of Bcl-2 in Breast Cancer: Correlation with
Clinicopathological Characteristics and Survival'. Acta medica, vol.51,
pp.107112.

Cheung, T. 2013. Endometrial Carcinoma. Journal of Paediatrics, Obstetrics &

Gynaecology, vol. 39, pp. 37- 44.

Chhieng D, Hui P, 2011. 'Endometrial Epithelial Neoplasms', In: Giordano A, (ed.).

Cytology and Surgical Pathology of Gynecologic Neoplasms. New york:
Springer. pp. 91-97.
 64

Crum C.P, Luska L.R, Nucci M.R, 2011. 'Adenocarcinoma, Carcinosarcoma, and
Other Epithelial Tumors of the Endometrium', In: Crum C.P, Nucci M.R,
LEE K.R (ed.) Diagnostic Gynecologic and Obstetric Pathology. Second
ed. Philadelphia: Elsevier. pp. 517-65.

Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, 2011.

'Endometrial Cancer: ESMO Clinical Practice Guidelines for Diagnosis,
Treatment and Follow-up'. Annals of Oncology, vol.22, pp.35 - 39.

Dorjgochoo T, Xiang Y.B, Long J, Jiajun Shi, Deming S, Wang-Hong Xu, et.al.,
2013. 'Association of Genetic Markers in the BCL-2 Family of Apoptosis-
Related Genes with Endometrial Cancer Risk in a Chinese Population',
Open-Access, vol. 8, pp. 1-9.

Driak, Dvorska, Svandova, Sehnal, Benkova, Spurkova, Halaska, 2011. 'Changes

in Expression of some Apoptotic Markers in Different Types of Human
Endometrium'. Folia Biologica, vol.57, pp.104-111.

Ellenson L.H, Pirog E.C, 2015. The Female Genital Tract. In: Kumar, Abbas,
Aster (ed.) Robbins and Cotran Pathologic Basis of Disease. 9th Edition
ed. Philadelphia,: Elsevier. 1013-1018.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et.al., 2012.

Cancer Incidence and Mortality Worldwide: IARC CancerBase. Globocan.

Ghani L, 2009. 'Seluk Beluk Menopause', Media Peneliti dan Pengembang

Kesehatan: Puslitbang Biomedis dan Farmasi, vol 11, pp 193-197.

Ghobrial I.M, Witzig T.E, Adjei AA, 2005. 'Targeting Apoptosis Pathways in
Cancer Therapy', CA Cancer J Clin, vol.55, pp.178 194.

Guntupalli S.R, Zighelboim I, Kizer N.T, Qin Zhang, Powell M.A, Thaker P.H,
Goodfellow P.J, Mutch D.G, 2012. 'Lymphovascular Space Invasion is an
Independent Risk Factor for Nodal Disease and Poor Outcomes in
Endometrioid Endometrial Cancer. Gynecol Oncol, vol.124, pp.3135.

Guset, Costi, Lazar, Dema, Lazureanu, Vernic et al, 2010. Bcl-2 Expression in
Endometrial Carcinoma in Relation to Different Histopathologic
Prognostic Factors. Journal of Experimental medical & Surgical Research
vol. 17, no. 4, pp. 251-254.

Helpman L, Kupets R, Covens A, Saad R.S, Khalifa M.A, Ismiil N, Ghorab Z, Dube
V, Nofech-Mozes, 2014. 'Assessment of Endometrial Sampling as a
Predictor of Final Surgical Pathology in Endometrial Cancer'. British
Journal of Cancer, vol.110, pp.609615.

Holman L & Lu K, 2012. 'The Epidemiology of Endometrial Cancer', Glob. libr.

women's med, vol 10, pp 3843.
 65

Jackson A, Bandera E, Clinton S, Giovannucci E, Hursting S, Leitzmann M,et.al.,

2013, Endometrial Cancer 2013. Report, Food, Nutrition, Physical Activity,
and the Prevention of Endometrial Cancer. World Cancer Research Fund.
1-30

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun
MJ, 2006. 'Cancer Statistics'. A Cancer Journal for Clinicians, vol.55, pp
10-30.

Kang S, Todo Y, Watari H, 2014. 'Risk Assessment of Lymph Node Metastasis

Before Surgery in Endometrial Cancer: Do We Need a Clinical Trial for
Low-Risk Patients?'. J. Obstet. Gynaecol. Res, vol.40, pp.322-326.

Kurman R.J, Ellenson L.H, Ronnett B.M, 2011. 'Endometrial Carcinoma. In:
Kurman R.J, Ellenson L.H, Ronnett B. M (ed.), Blausteins Pathology of the
Female Genital Tract. sixth ed. New York: Springer, pp.393-452.

LaxSF, 2007. 'Molecular genetic changes in epithelial, stromal and mixed

neoplasms of the endometrium'. Pathology, vol 39, pp 46-54.

Maksem J.A, Stanley. J, Robboy, Bishop J.W, Meiers I, 2009. 'Endometrial

carcinoma', In: Ali S.Z, Clark D.P, Erozan Y.S, (ed.) Endometrial Cytology
with Tissue Correlations. New York: Springer. pp. 231-256.

Malik S. G. 2010. 'Peran Mitokondra pada Kanker: Mitokondria, Life and Death.
In: Aman R.A, Gondhowiardjo S, Rachman A, Suriadiredja A, Syahruddin
E, Tobing D.L, Munandar A, Kodrat H (ed.), Basic Science of Oncology.
Jakarta: Perhimpunan Onkologi Indonesia, FK UI. 223-228

Marcia L, Appel, Maria I, et al., 2008. 'P53 and Bcl-2 as Prognostic Markers in
Endometrial Carcinoma'.Pathol.Oncol.Res. vol 14, pp. 23-30

Mariani A, Sebo T.J, Cliby W.A, Keeney G.L, Riehle D.L, Lesnick T.G and
Podratz K.C, 2006. Role of Bcl-2 in Endometrioid Corpus Cancer: An
Experimental Study. Anticancer Research, vol.26, pp.823-828.

Martin L.A and Dowsett M, 2013. 'BCL-2: A New Therapeutic Target in Estrogen
Receptor-Positive Breast Cancer?' Cancer Cell, vol.24, pp.7-9.

Milam M.R, Java J, Walker J.L, Metzinger D.S, Parker L.P, Coleman R.L, 2012.
'Nodal Metastasis Risk in Endometrioid Endometrial Cancer. Obstet
Gynecol vol.119, pp.286-292.

Murali R, Soslow R.A, Weigelt B, 2014. 'Classification of Endometrial Carcinoma:

More Than Two Types'. Lancet Oncol, vol.15, pp.268278.

Nurseta T, Andrijono, Soetrisno E, 2008. Ekspresi MMP-2 dan TIMP-2 Karsinoma

Endometrium Operabel pada Lapisan Endometrium dan Miometrium
 66

sebagai pertanda terjadinya Invasi Miometrium dan Metastasis KGB Pelvis.

Indonesian Journal of Obstetrics and Gynecologhy, vol. 32, no. 4, pp.229-
236.
Porichi, Nikolaidou, Apostolaki, Tserkezoglou, Arnogiannaki, Kassanos,
Margaritis, Panotopoulou, 2009. 'BCL-2, Bax, and P53 Expression Profiles
in Endometrial Carcinoma as Studied by Real Time PCR and
Immunohistochemistry'. Anticancer research, vol.29, pp.3977-3982.

Rosai J, 2011. Female Reproductive Systim. In: M. Houston, (ed.), Surgical

Pathology. 10 ed. British: Elsevier. 1477-1519.

Rodilla I.G, Verna V, Munoz A.B, Estevez J, Boix M, Schneider J, 2011.

'Expression of the Apoptosis-Related Genes Bcl-2 and p53 in Clinical
Samples from Endometrial Carcinoma Patients'. Anticancer research,
vol.31, pp.4191-4194.

Rose A.G, 2008. 'Female Genital Tract and Breast', Atlas of Gross Pathology with
Histologic Correlation. New York: Cambridge University Press. pp. 358-
427.

Saegusa, M., Kamata, Y., Isono, M., and Okayasu, I., 1996. 'Bcl-2 expression is
correlated with a low apoptotic index and associated with progesterone-
receptor immunoreactivity in endometrial carcinoma'. J. Pathol, vol 180, pp
275-282.

Salvesen H.B, Haldorsen I.S, Trovik J, 2012. 'Markers for Individualised Therapy
in Endometrial Carcinoma. Lancet Oncol vol.13, pp.353361

Siegel R, Naishadham D,Jjemal A. 2012. 'Cancer statistics 2012'. CA Cancer J Clin,

vol.62, pp.1029.

Silverberg S,G, Kurman R.J, Nogales F, 2003. 'Epithelial Tumours and Related
Lesions', In: Kleihues P, Sobin L.H (ed.) WHO Pathology and genetics of
Tumours of The Breast and Female Genital Organs, IARC, Lyon: France,
pp. 220-232.

Tangjitgamol S, Anderson B.O, Hui Ti See, Lertbutsayanukul C, Sirisabya N,

Manchana T, Ilancheran A, et al., 2009. 'Management of Endometrial
Cancer in Asia: Consensus Statement from the Asian Oncology Summit
2009'. Lancet oncol, vol.10, pp.111927

Varughese J, Richman S, 2010. 'Cancer Care Inequity for Women in Resource-Poor

Countries', Reviews in Obstetrics & Gynecology, vol. 3, pp. 122-132.

Werner H.M.J, Trovik J, Marcickiewicz J, Tingulstad S, Staff A.C, Amant F,

Salvesen H.B, MoMaTEC study group, 2012. 'Revision of FIGO Surgical
Staging in 2009 for Endometrial Cancer Validates to Improve Risk
Stratification'. Gynecologic Oncology, vol.125, pp.103-108.
 67

Werner H.M.J, Trofik J, Marcickiewicz J, Tingulstad S, Staff A.C, Engh M.E,

Oddenes K, Rokne J.A, Tjugum J, Lode M.S, Amant F, Salvesen H.B, 2013.
'A Discordant Histological Risk Classification in Preoperative and
Operative Biopsy in Endometrial Cancer is Reflected in Metastatic Risk and
Prognosis'. European Journal of Cancer, vol.49, pp.625-632.

Young B, Lowe J.S, Stevens A, Heath J.W, 2007. Female Reproductive System.
Wheater's Functional Hystology A Text and Colour Atlas. 5th ed.: Elsevier.
pp.359-375

Zaki M.A, Robbins J.R, Fatteh S, Mahan M.G, Hanna R.K, Elshaikh M.A, 2012,
Histological grade predicts for recurrence in patients with uterine
endometrioid carcinoma without myometrial involvement, Anticancer
research, vol 32, pp 4061-4066